BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8846834)

  • 1. Thermodynamics of 5-HT3 receptor binding discriminates agonistic from antagonistic behaviour.
    Borea PA; Dalpiaz A; Gessi S; Gilli G
    Eur J Pharmacol; 1996 Mar; 298(3):329-34. PubMed ID: 8846834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour.
    Gessi S; Fogli E; Sacchetto V; Varani K; Merighi S; Leung E; Lennan SM; Borea PA
    Biochem Pharmacol; 2008 Jan; 75(2):562-9. PubMed ID: 17936250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding thermodynamics of adenosine A2a receptor ligands.
    Borea PA; Dalpiaz A; Varani K; Guerra L; Gilli G
    Biochem Pharmacol; 1995 Feb; 49(4):461-9. PubMed ID: 7532939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding thermodynamics of 5-HT1A receptor ligands.
    Dalpiaz A; Borea PA; Gessi S; Gilli G
    Eur J Pharmacol; 1996 Sep; 312(1):107-14. PubMed ID: 8891585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding thermodynamics at the human neuronal nicotine receptor.
    Borea PA; Varani K; Gessi S; Gilli P; Gilli G
    Biochem Pharmacol; 1998 Apr; 55(8):1189-97. PubMed ID: 9719473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding thermodynamics of serotonin to rat-brain 5-HT1A, 5HT2A and 5-HT3 receptors.
    Dalpiaz A; Gessi S; Borea PA; Gilli G
    Life Sci; 1995; 57(12):PL141-6. PubMed ID: 7674802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
    Merighi S; Simioni C; Gessi S; Varani K; Borea PA
    Biochem Pharmacol; 2010 Feb; 79(3):471-7. PubMed ID: 19766600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations into the thermodynamics of polypeptide interaction with nonpolar ligands.
    Hearn MT; Zhao G
    Anal Chem; 1999 Nov; 71(21):4874-85. PubMed ID: 10565277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors.
    Varani K; Surprenant A; Vincenzi F; Tosi A; Gessi S; Merighi S; Borea PA
    Biochem Pharmacol; 2008 Mar; 75(5):1198-208. PubMed ID: 18076867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamics of gamma-aminobutyric acid type A receptor binding differentiate agonists from antagonists.
    Maksay G
    Mol Pharmacol; 1994 Aug; 46(2):386-90. PubMed ID: 8078501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding thermodynamics at the human A(3) adenosine receptor.
    Merighi S; Varani K; Gessi S; Klotz KN; Leung E; Baraldi PG; Borea PA
    Biochem Pharmacol; 2002 Jan; 63(2):157-61. PubMed ID: 11841789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of temperature on the creatine kinase equilibrium.
    Teague WE; Dobson GP
    J Biol Chem; 1992 Jul; 267(20):14084-93. PubMed ID: 1629208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor binding thermodynamics as a tool for linking drug efficacy and affinity.
    Borea PA; Varani K; Gessi S; Gilli P; Dalpiaz A
    Farmaco; 1998 Apr; 53(4):249-54. PubMed ID: 9658581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type.
    Waelbroeck M; Camus J; Tastenoy M; Lambrecht G; Mutschler E; Kropfgans M; Sperlich J; Wiesenberger F; Tacke R; Christophe J
    Br J Pharmacol; 1993 Jun; 109(2):360-70. PubMed ID: 8102927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic studies with acetylthiocholine on nicotinic receptors of mammalian skeletal muscle in vitro.
    Banerjee B; Ganguly DK
    Biochem Pharmacol; 1995 May; 49(11):1713-6. PubMed ID: 7786312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct thermodynamic parameters of serotonin 5-HT3 agonists and antagonists to displace [3H]granisetron binding.
    Maksay G
    J Neurochem; 1996 Jul; 67(1):407-12. PubMed ID: 8667020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors.
    Dalpiaz A; Townsend-Nicholson A; Beukers MW; Schofield PR; IJzerman AP
    Biochem Pharmacol; 1998 Dec; 56(11):1437-45. PubMed ID: 9827575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
    Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
    Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding to the serotonin 5HT3 receptor studied with a novel fluorescent ligand.
    Tairi AP; Hovius R; Pick H; Blasey H; Bernard A; Surprenant A; Lundström K; Vogel H
    Biochemistry; 1998 Nov; 37(45):15850-64. PubMed ID: 9843391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.